Relative bioavailability of topiramate administered rectally

Epilepsy Research

Volumn 54, Issue 2-3, 2003, Pages 91-96

  Conway, Jeannine M ^a   Birnbaum, Angela K ^a   Kriel, Robert L ^a,b   Cloyd, James C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Bioavailability; Rectal administration; Topiramate

Indexed keywords

TOPIRAMATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; SEIZURE; SENSORY DYSFUNCTION; SOMNOLENCE; SPEECH DISORDER; VERTIGO; VISUAL DISORDER;

EID: 0038771152     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(03)00083-4     Document Type: Article

References (23)

1. Birnbaum A.K., Kriel R.L.et al. Rectal absorption of lamotrigine compressed tablets. Epilepsia. 41(7):2000;850-853.
2. Birnbaum A.K., Kriel R.L.et al. Relative bioavailability of lamotrigine chewable dispersible tablets administered rectally. Pharmacotherapy. 21(2):2001;158-162.
3. Biton V., Montouris G.D.et al. A randomized placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology. 52(7):1999;1330-1337.
4. Burstein A.H., Fisher K.M.et al. Absorption of phenytoin from rectal suppositories formulated with a polyethylene glycol base. Pharmacotherapy. 20(5):2000;562-567.
5. Cloyd J.C., Kriel R.L. Bioavailability of rectally administered valproic acid syrup. Neurology. 31(10):1981;1348-1352.
6. Cloyd J.C., Lalonde R.L.et al. A single-blind, crossover comparison of the pharmacokinetics and cognitive effects of a new diazepam rectal gel with intravenous diazepam. Epilepsia. 39(5):1998;520-526.
7. Dhillon S., Oxley J.et al. Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients. Br. J. Clin. Pharmacol. 13(3):1982;427-432.
8. Doose D.R., Walker S.A.et al. Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug. J. Clin. Pharmacol. 36(10):1996;884-891.
9. Gidal B.E., Lensmeyer G.L. Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography method. Ther. Drug Monit. 21(5):1999;567-576.
10. Glauser T.A., Clark P.O.et al. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia. 39(12):1998;1324-1328.
11. Graves N.M., Kriel R.L.et al. Relative bioavailability of rectally administered carbamazepine suspension in humans. Epilepsia. 26(5):1985;429-433.
12. Graves N.M., Holmes G.B.et al. Relative bioavailability of rectally administered phenobarbital sodium parenteral solution. Dicp. 23(7/8):1989;565-568.
13. Johnson & Johnson Pharmaceutical Research Institute Topamax (topiramate) Data on File. Raritian, NJ.
14. Kriel R.L., Birnbaum A.K.et al. Failure of absorption of gabapentin after rectal administration. Epilepsia. 38(11):1997;1242-1244.
15. Krumholz A., Grufferman S.et al. Seizures and seizure care in an emergency department. Epilepsia. 30(2):1989;175-181.
16. Matsukura M., Higashi A.et al. Bioavailability of phenobarbital by rectal administration. Pediatr. Pharmacol. 1(3):1981;259-265.
17. Minagawa K., Miura H.et al. Pharmacokinetics of rectal diazepam in the prevention of recurrent febrile convulsions. Brain Dev. 8(1):1986;53-59.
18. Remy C., Jourdil N.et al. Intrarectal diazepam in epileptic adults. Epilepsia. 33(2):1992;353-358.
19. Sachdeo R.C., Glauser T.A.et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology. 52(9):1999;1882-1887.
20. Shank R.P., Gardocki J.F.et al. Topiramate: preclinical evaluation of structurally novel anticonvulsant. Epilepsia. 35(2):1994;450-460.
21. Shargel, L., Yu, A., 1999. Applied Biopharmaceutics and Pharmacokinetics. Samford, Appleton and Lange.
22. Stanaway L., Lambie D.G.et al. Non-compliance with anticonvulsant therapy as a cause of seizures. N. Z. Med. J. 98(774):1985;150-152.
23. Wheless J.W. Use of topiramate in childhood generalized seizure disorders. J. Child. Neurol. 15(Suppl. 1):2000;S7-S13.